QUALITY OF LIFE AND FERTILITY IN HODGKIN DISEASE PATIENTS TREATED WITH ESCALATED BEACOPP

被引：0
|
作者：
Jurczak, W. [1 ]
Krochmalczyk, D. [1 ]
Pabian, W. [2 ]
Chrapczynski, P. [3 ]
Cwierz, A. [3 ]
Giza, A. [1 ]
Sobocinski, M. [1 ]
Zimowska-Curylo, D. [1 ]
Skotnicki, A. B. [1 ]
机构：
[1] Dept Hematol, Krakow, Poland
[2] CMUJ, Ob Gyn Clin, Krakow, Poland
[3] Stdent Sci Assoc CMUJ, Krakow, Poland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0089
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [21] PET2-driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP
    Deau, Benedicte
    Franchi, Patricia
    Briere, Josette
    Ohnona, Jessica
    Tamburini, Jerome
    Thieblemont, Catherine
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (02) : 278 - 281
  • [22] Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?
    Bruce D. Cheson
    Current Hematologic Malignancy Reports, 2014, 9 : 222 - 226
  • [23] Which Hodgkin's Patients in the Unites States Should Be Treated with BEACOPP?
    Cheson, Bruce D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (03) : 222 - 226
  • [24] Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with or without radiotherapy in patients in advanced stage Hodgkin lymphoma (HL): Final analysis of the HD12 trial of the German Hodgkin Study Group (GHSG)
    Diehl, V.
    Haverkamp, H.
    Mueller, R.
    Mueller-Hermelink, H.
    Cerny, T.
    Markova, J.
    Ho, A. D.
    Kanz, L.
    Greil, R.
    Engert, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Osteonecrosis in Hodgkin lymphoma treated by BEACOPP Reply
    Basic-Kinda, Sandra
    Karlak, Ivan
    Durakovic, Nadira
    Lubina, Zvonimir Ivan
    Radman, Ivo
    Dotlic, Snjezana
    Peric, Zinaida
    Hude, Ida
    Aurer, Igor
    INTERNAL MEDICINE JOURNAL, 2018, 48 (06) : 748 - 748
  • [26] Modified Escalated BEACOPP Regimen, an Acceptable Alternative to ABVD for the Management of Hodgkin's Disease (HD) in Developing Countries!
    Sharma, D. S.
    Somani, N.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S590 - S590
  • [27] BEACOPP (basic & modified escalated) chemotherapy for Hodgkin's disease (HD): A cost effective protocol in developing country
    Somani, Naresh
    Agarwal, P. K.
    Patni, N.
    Parikh, A.
    Gupta, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 155 - 155
  • [28] Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated followed by 4 Cycles of BEACOPP Baseline with or without Radiotherapy in Patients in Advanced-stage Hodgkin Lymphoma (HL): Final Analysis of the Randomized HD12 Trial of the German Hodgkin Study Group (GHSG)
    Eich, H.
    Engert, A.
    Haverkamp, H.
    Staar, S.
    Kriz, J.
    Engenhart-Cabillic, R.
    Lukas, P.
    Willich, N.
    Diehl, V.
    Mueller, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S3 - S4
  • [29] Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with our without radiotherapy in patients in advanced stage Hodgkin Lymphoma (HL): Final analysis of the randomised HD12 trial of the German Hodgkin Study Group (GHSG)
    Eich, H. T.
    Mueller, R-P.
    Haverkamp, H.
    Gossmann, A.
    Staar, S.
    Kriz, J.
    Lukas, P.
    Willich, N.
    Engenhart-Cabillic, R.
    Engert, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 26 - 26
  • [30] COMPARISON BETWEEN BEACOPP-ESCALATED AND ABVD-INCLUDING CHEMOTHERAPY FOR HODGKIN LYMPHOMA PATIENTS: A SYSTEMATIC REVIEW
    Bauer, K.
    Brillant, C.
    Monsef, I
    Skoetz, N.
    Engert, A.
    HAEMATOLOGICA, 2010, 95 : S24 - S24
12345